Daniel Oruzio

2.6k total citations
30 papers, 658 citations indexed

About

Daniel Oruzio is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Oruzio has authored 30 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 6 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Oruzio's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal and Anal Carcinomas (5 papers). Daniel Oruzio is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal and Anal Carcinomas (5 papers). Daniel Oruzio collaborates with scholars based in Germany, United States and Estonia. Daniel Oruzio's co-authors include Michael Schleuning, Bruno Märkl, Matthias Anthuber, Marcus Hentrich, H Arnholdt, Hendrik Jähnig, Hanno Spatz, Wolfgang Hiddemann, Xaver Schiel and Hans‐Jochem Kolb and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Daniel Oruzio

28 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Oruzio Germany 14 426 149 104 103 96 30 658
Eric Raefsky United States 14 396 0.9× 244 1.6× 195 1.9× 54 0.5× 97 1.0× 46 835
Vivek A. Bhadri Australia 13 187 0.4× 160 1.1× 84 0.8× 74 0.7× 63 0.7× 35 559
Martin Görner Germany 13 585 1.4× 215 1.4× 82 0.8× 234 2.3× 50 0.5× 23 939
Cynthia Helsabeck United States 11 224 0.5× 51 0.3× 60 0.6× 52 0.5× 127 1.3× 15 553
Yee Chung Cheng United States 12 458 1.1× 103 0.7× 150 1.4× 91 0.9× 168 1.8× 39 745
Angelo Palmas Italy 8 216 0.5× 111 0.7× 141 1.4× 57 0.6× 125 1.3× 18 486
Klaus Fenchel Germany 14 340 0.8× 164 1.1× 133 1.3× 65 0.6× 109 1.1× 31 855
Andrea Kerkhoff Germany 14 360 0.8× 119 0.8× 57 0.5× 91 0.9× 184 1.9× 33 578
Gregg A. Olsen United States 11 417 1.0× 103 0.7× 213 2.0× 79 0.8× 205 2.1× 17 752
Phillip Periman United States 13 293 0.7× 180 1.2× 131 1.3× 76 0.7× 53 0.6× 26 693

Countries citing papers authored by Daniel Oruzio

Since Specialization
Citations

This map shows the geographic impact of Daniel Oruzio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Oruzio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Oruzio more than expected).

Fields of papers citing papers by Daniel Oruzio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Oruzio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Oruzio. The network helps show where Daniel Oruzio may publish in the future.

Co-authorship network of co-authors of Daniel Oruzio

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Oruzio. A scholar is included among the top collaborators of Daniel Oruzio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Oruzio. Daniel Oruzio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Märkl, Bruno, Nadia Harbeck, Reinhard Hoffmann, et al.. (2019). Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer. BMC Cancer. 19(1). 692–692. 8 indexed citations
2.
Märkl, Bruno, et al.. (2016). Circulating cytokeratin-positive cells and tumor budding in colorectal cancer. World Journal of Clinical Oncology. 7(6). 433–433. 3 indexed citations
3.
Cacchi, Claudio, H Arnholdt, Hendrik Jähnig, et al.. (2012). Clinical significance of lymph vessel density in T3 colorectal carcinoma. International Journal of Colorectal Disease. 27(6). 721–726. 8 indexed citations
4.
Schmidt, Marcus, Dominik Rüttinger, Martin Sebastian, et al.. (2012). Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer. Annals of Oncology. 23(9). 2306–2313. 40 indexed citations
5.
Stintzing, Sebastian, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser, et al.. (2011). Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial. British Journal of Cancer. 105(2). 206–211. 22 indexed citations
6.
Schmid, Christoph, Michael Schleuning, Johanna Tischer, et al.. (2011). Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study. Bone Marrow Transplantation. 47(1). 46–53. 27 indexed citations
7.
Märkl, Bruno, H Arnholdt, Hendrik Jähnig, et al.. (2010). A New Concept for the Role of Ex vivo Sentinel Lymph Nodes in Node-Negative Colorectal Cancer. Annals of Surgical Oncology. 17(10). 2647–2655. 14 indexed citations
8.
Haferlach, Claudia, Frank Dicker, Tamara Weiss, et al.. (2010). Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters. Genes Chromosomes and Cancer. 49(9). 851–859. 40 indexed citations
9.
Weikersthal, Ludwig Fischer von, Andreas Schalhorn, Martina Stauch, et al.. (2010). Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. European Journal of Cancer. 47(2). 206–214. 43 indexed citations
10.
Märkl, Bruno, H Arnholdt, Hendrik Jähnig, et al.. (2010). Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. Human Pathology. 41(7). 1024–1033. 23 indexed citations
11.
Märkl, Bruno, Daniel Oruzio, Hendrik Jähnig, et al.. (2010). Tumour budding, uPA and PAI‐1 are associated with aggressive behaviour in colon cancer. Journal of Surgical Oncology. 102(3). 235–241. 38 indexed citations
12.
Moosmann, Nicolas, Ludwig Fischer von Weikersthal, Martina Stauch, et al.. (2010). Final analysis of the randomized trial of the German AIO CRC study group: Cetuximab plus XELIRI versus cetuximab plus XELOX as first-line treatment for patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 28(15_suppl). 3540–3540. 15 indexed citations
13.
Spatz, Hanno, Andreas Probst, Daniel Oruzio, et al.. (2009). Sentinel lymph node mapping as a side-effect of colonoscopic tattooing. Surgical Endoscopy. 24(3). 589–593. 11 indexed citations
14.
Schmid, Christoph, Michael Schleuning, Marcus Hentrich, et al.. (2008). High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. Bone Marrow Transplantation. 41(8). 721–727. 49 indexed citations
15.
Märkl, Bruno, Hendrik Jähnig, Daniel Oruzio, et al.. (2008). Methylene Blue–Assisted Lymph Node Dissection in Colon Specimens. American Journal of Clinical Pathology. 130(6). 913–919. 44 indexed citations
16.
Sandherr, Michael, et al.. (2007). 65-jährige Patientin mit Thrombopenie und Hyperfibrinolyse bei Mammakarzinom. Der Internist. 48(9). 1015–1019. 2 indexed citations
17.
Hentrich, Marcus, Daniel Oruzio, Gundula Jäger, et al.. (2004). Impact of human herpesvirus‐6 after haematopoietic stem cell transplantation. British Journal of Haematology. 128(1). 66–72. 108 indexed citations
18.
Oruzio, Daniel, et al.. (2004). Results from a phase I clinical trial with IGN311, a fully humanized IgG1 antibody against Lewis Y in patients with solid tumors expressing Lewis Y antigen. Journal of Clinical Oncology. 22(14_suppl). 2624–2624. 1 indexed citations
19.
20.
M�ller, Peter, et al.. (1998). Sequential immunotyping and genotyping of tumor cells in bone marrow of cancer patients: A model study. Cytometry. 33(4). 492–497. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Raefsky Breakdown of academic impact, for papers by Vivek A. Bhadri Breakdown of academic impact, for papers by Martin Görner Breakdown of academic impact, for papers by Cynthia Helsabeck Breakdown of academic impact, for papers by Yee Chung Cheng Breakdown of academic impact, for papers by Angelo Palmas Breakdown of academic impact, for papers by Klaus Fenchel Breakdown of academic impact, for papers by Andrea Kerkhoff Breakdown of academic impact, for papers by Gregg A. Olsen Breakdown of academic impact, for papers by Phillip Periman
Rankless by CCL
2026